Agreed but the evidence supports this. The vast array of evidence just is not widely known or understood. When a German doctor communicates with a German patient’s wife that L should be available in 2020 and causes her to believe that her husband would have been placed into the SOC/placebo arm if enrolled, that kind of is a big deal when enrollment numbers from Germany never get shared. By the way, there was also an analyst report that came out 4 or 5 years ago I think that suggested L would be available in 2018 based on then current due diligence. They have been silent since then. Best wishes.
News 
Market Data 
Discover 
AI
